Catheter Precision Statistics
Share Statistics
Catheter Precision has 8.00M shares outstanding. The number of shares has increased by 29.74% in one year.
| Shares Outstanding | 8.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -62.97% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 7.51M |
| Failed to Deliver (FTD) Shares | 9.27K |
| FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 183.68K, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 183.68K |
| Short % of Shares Out | 2.29% |
| Short % of Float | 2.58% |
| Short Ratio (days to cover) | 0.02 |
Valuation Ratios
The PE ratio is -0.31 and the forward PE ratio is -0.13.
| PE Ratio | -0.31 |
| Forward PE | -0.13 |
| PS Ratio | 50.23 |
| Forward PS | 0.3 |
| PB Ratio | 1.05 |
| P/FCF Ratio | -1.07 |
| PEG Ratio | n/a |
Enterprise Valuation
Catheter Precision Inc. has an Enterprise Value (EV) of -971.37K.
| EV / Earnings | 0.01 |
| EV / Sales | -2.2 |
| EV / EBITDA | 0.06 |
| EV / EBIT | 0.01 |
| EV / FCF | 0.05 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.68 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.86 |
| Cash Flow / Debt | -112.06 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -3.33% and return on capital (ROIC) is -362.27%.
| Return on Equity (ROE) | -3.33% |
| Return on Assets (ROA) | -2.3% |
| Return on Capital (ROIC) | -362.27% |
| Revenue Per Employee | 31.57K |
| Profits Per Employee | -5.04M |
| Employee Count | 14 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.68 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -92.29% in the last 52 weeks. The beta is 0, so Catheter Precision 's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -92.29% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 2.9 |
| Relative Strength Index (RSI) | 39.83 |
| Average Volume (20 Days) | 3.59M |
Income Statement
In the last 12 months, Catheter Precision had revenue of $442.00K and earned -$70.57M in profits. Earnings per share was $-12.99.
| Revenue | 442.00K |
| Gross Profit | 412.00K |
| Operating Income | -78.12M |
| Net Income | -70.57M |
| EBITDA | -15.11M |
| EBIT | -78.12M |
| Earnings Per Share (EPS) | -12.99 |
Balance Sheet
The company has $3.56M in cash and $372.00K in debt, giving a net cash position of $3.19M.
| Cash & Cash Equivalents | 3.56M |
| Total Debt | 372.00K |
| Net Cash | 3.19M |
| Retained Earnings | -275.71M |
| Total Assets | 26.75M |
| Working Capital | -872.00K |
Cash Flow
In the last 12 months, operating cash flow was -$20.62M and capital expenditures -$76.00K, giving a free cash flow of -$20.70M.
| Operating Cash Flow | -20.62M |
| Capital Expenditures | -76.00K |
| Free Cash Flow | -20.70M |
| FCF Per Share | -3.77 |
Margins
Gross margin is 93.21%, with operating and profit margins of -17.67K% and -15.97K%.
| Gross Margin | 93.21% |
| Operating Margin | -17.67K% |
| Pretax Margin | -15.97K% |
| Profit Margin | -15.97K% |
| EBITDA Margin | -3.42K% |
| EBIT Margin | -17.67K% |
| FCF Margin | -4.68K% |
Dividends & Yields
VTAK does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -3510.81% |
| FCF Yield | -700.08% |
Analyst Forecast
Currently there are no analyst rating for VTAK.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Jul 15, 2024. It was a backward split with a ratio of 1:10.
| Last Split Date | Jul 15, 2024 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -16.39 |
| Piotroski F-Score | 3 |